Rapid influenza Diagnostic Tests Market to register substantial growth by 2025

October 18, 2019


According to the latest study titled ‘Global Rapid Influenza Diagnostic Test (RIDT) Market Insights, Forecast to 2025’ available with Market Study Report LLC, the global rapid influenza diagnostic tests market is estimated to grow substantially by the year 2025.
 

Rapid influenza diagnostic test (RIDT) is a biochemical test known as immunoassay, enabling the identification of influenza A and B viral nucleoprotein antigens in respiratory specimens. These tests are used in clinical decision making to assist in the diagnostic and treatment of patients. RIDTs are characterized by ease of usability and fast results. Growing prevalence of respiratory disorders among the global population is the main factor propelling the RIDT market growth. Other factors fueling the market growth are increasing government initiatives to counter influenza and rising investments in the detection of chronic diseases such as heart and blood disorders and diabetes.
 

The study analyzes rapid influenza diagnostic tests market for revenue shares, growth patterns, and price trends for each segment and manufacturer. It also provides a detailed synopsis of trends, challenges, distribution channels, marketing strategies, consumer spectrum, restraints, opportunities, and drivers impacting the market growth. 
 

Based on type, the rapid influenza diagnostic tests market is bifurcated as conventional RIDT and digital RIDTs. While based on application spectrum, the market is divided into laboratories, hospitals & clinics, and others.
 

Request sample copy of this Reporthttps://www.marketstudyreport.com/request-a-sample/2034090/
 

Considering the geographical landscape, the global RIDT industry is fragmented into five main regions. Central & South America consists of Brazil; Germany, Russia, UK, France, and Italy combines to form Europe; Asia Pacific comprises of India, China, Japan, Indonesia, Korea, Australia, Malaysia, Thailand, Vietnam, and Philippines; North America is composed of Canada, Mexico, and US; and Egypt, South Africa, Turkey, and GCC Countries fall under Middle East & Africa. 
 

The key contenders of rapid influenza diagnostic tests market outlined in the report are Roche Diagnostics, Thermo Fisher Scientific, Quidel Corporation, Abbott, Dickinson and Company, Becton, SA Scientific Ltd., DiaSorin, Analytik Jena AG (Endress+Hauser AG), Luminex Corporation, and Meridian Bioscience, Inc.


Frequently Asked Questions (FAQ) :

The report splits RIDT market into 3 segments in terms of the application spectrum. These include laboratories, hospitals & clinics, and others.
Growing prevalence of respiratory disorders among the global population is the main factor propelling the RIDT market growth. Other factors fueling the market growth are increasing government initiatives to counter influenza and rising investments in the detection of chronic diseases such as heart and blood disorders and diabetes.
Considering the geographical landscape, the global RIDT industry is fragmented into five main regions. Central & South America consists of Brazil; Germany, Russia, UK, France, and Italy combines to form Europe; Asia Pacific comprises of India, China, Japan, Indonesia, Korea, Australia, Malaysia, Thailand, Vietnam, and Philippines; North America is composed of Canada, Mexico, and US; and Egypt, South Africa, Turkey, and GCC Countries fall under Middle East & Africa.
The key contenders of rapid influenza diagnostic tests market outlined in the report are Roche Diagnostics, Thermo Fisher Scientific, Quidel Corporation, Abbott, Dickinson and Company, Becton, SA Scientific Ltd., DiaSorin, Analytik Jena AG (Endress+Hauser AG), Luminex Corporation, and Meridian Bioscience, Inc.